Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

3,511 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Proposed Amendments To Ontario Regulations To Streamline Administrative Process, Change OCT Payment Limit, And Reduce Government Payments To Pharmacies

    On October 28, 2019, the Ontario Ministry of Health and Long-Term Care (the Ministry) published proposed changes to Regulations made under the Ontario Drug Benefit Act (ODBA)...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Provinces And Territories Take First Step On A Pan-Canadian Approach To Management Of Drug Costs

    On January 18, 2013, the Canadian provinces and territories (with the exception of Quebec) announced a joint initiative designed to achieve significant cost savings for publicly funded drug plans.
    CanadaFood, Drugs, Healthcare, Life Sciences
Fasken
Fasken
  • Article

    Recreational Cannabis In The U.S.A: Colorado

    Whitney Abrams continues to review the recreational cannabis regimes across the U.S.A. This week she provides an update on the regime in Colorado. ​
    CanadaFood, Drugs, Healthcare, Life Sciences
    Minden Gross LLP
    Minden Gross LLP
  • Article

    Reducing Antibiotics In Meat: The Proposal To Remove Growth Promotion Claims From Vet Drugs

    Health Canada and the Canadian Animal Health Institute introduced measures to promote the more prudent use of antimicrobials in animal production.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Article

    Regulatory Myths (Part 1)

    While most media and academic attention is devoted to what happens in legislatures and to the statutes they produce, most governing is done through the enactment and enforcement of regulations.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Article

    Secteur Agroalimentaire

    En cette période d'incertitude et compte tenu du contexte juridique et réglementaire qui évolue rapidement, le secteur agroalimentaire
    CanadaFood, Drugs, Healthcare, Life Sciences
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Self-Care Regulations To Get A Make Over

    Health Canada not only regulates prescription drugs sold in Canada, but also it regulates a wide variety of "self-care" products that can be purchased at health food stores, pharmacies and grocery stores.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Significant Changes To Canada's Cannabis Licensing Process

    Health Canada has issued a press release stating that it is changing the application process for licences to cultivate cannabis, process cannabis or sell cannabis for medical purposes (Commercial Licences).
    CanadaFood, Drugs, Healthcare, Life Sciences
    Blake, Cassels & Graydon LLP
    Blake, Cassels & Graydon LLP
  • Article

    Special Access Program And Emergency Drug Release Program Amendments In Force

    On September 28, 2020, the Regulations Amending Certain Regulations Made under the Food and Drugs Act (Sale of a New Drug for Emergency Treatment) (Regulations) came into force.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Supreme Court Denies Leave To Appeal In Proposed $3.9 Billion Class Action Against Generic Drug Manufacturers

    The Supreme Court of Canada has released today its judgment in the case of Option Consommateurs v. Novopharm et al dismissing, with costs, Option Consommateurs' application for leave to appeal from the decision of the Quebec Court of Appeal which had refused to authorize a proposed $3.9 billion class action instituted on behalf of all Quebecers against nine generic drug manufacturers.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Davies Ward Phillips & Vineberg LLP
    Davies Ward Phillips & Vineberg LLP
  • Article

    Sweet Dreams Are Made Of Cheese - Who Am I To Disagree?

    Nutmeg in large enough quantities can have powerful psychoactive effects providing a type of intoxication similar to the combination of alcohol and marijuana.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Article

    Technology, Healthcare M&A Picking Up, Helped By The Promise Of AI

    Aaron Sonshine comments on positive deal-making trends in technology and healthcare in Lexpert's special look at the sectors.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Bennett Jones LLP
    Bennett Jones LLP
  • Article

    The Balance Of Convenience In Judicial Review Applications—A Lesson In The Cannabis Space

    The Court held that the balance of convenience weighed against granting the requested remedy, even if the case had been made out on the merits.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Bennett Jones LLP
    Bennett Jones LLP
  • Article

    Three Big Trends In Agribusiness

    Growing investment in technology (AgTech) and innovation, Environment, Sustainability and Governance (ESG)...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Bennett Jones LLP
    Bennett Jones LLP
  • Article

    Top 10 Updates On Canadian Market Access, Exclusivity And Pricing Issues

    The article contains an overview of some of the most pertinent changes in market access, exclusivity and pricing that have occurred over the past year that will impact stakeholders operating in the Canadian pharmaceutical industry.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Update On New Tools For Food Directorate: Food Additive Submissions

    Health Canada has released a new guidance document and checklist for food additive submissions, concurrent with the transition to the food additive lists in place of the tables set out in the Food and Drug Regulations.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Article

    Update: "Taking The High Road" – Crossing The Canada/US Border Following The Legalization Of Cannabis

    In our previous blog post, we discussed the serious implications of cannabis affiliation at the U.S. Border.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Devry Smith Frank LLP
    Devry Smith Frank LLP
  • Article

    Updates From CADTH: Improvements To CADTH Reimbursement Review Process, Increased Fees And New Formulary Management Expert Committee Pilot

    The Canadian Agency for Drugs and Technologies in Health (CADTH) announced upcoming improvements to its Reimbursement Review process. CADTH will review its current process to identify...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    What's In A Name? Biosimilar Nonproprietary Names

    The U.S. federal government created a specially-designed, abbreviated biosimilar approval pathway
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    What About Mexico?

    Canada has long recognized export opportunities outside of North America and is working to expand market access in the EU and other emerging markets.
    CanadaFood, Drugs, Healthcare, Life Sciences
    MNP LLP
    MNP LLP
  • Showing 681–700 of 3511 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics